Selected Publications
LIPID METABOLISM (SELECTED PUBLICATIONS)
Tang Yi Chien and Das, A.* Role of Omega-3 and Omega-6 Endocannabinoids in Cardiopulmonary Pharmacology, Advances in Pharmacology Volume 97, Book Chapter. 2023
Arnold, W., Carnevale, L., Xie, Z., Baylon, J., Tajkhorshid, E., Hu, H., Das, A.*, "Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel " Nature Communications, 2021, https://www.nature.com/articles/s41467-021-20946-6
Das, A.*, Arnold, W.*, Weigle, A.*, Kim, J., Carnevale, L., and Huff, H., "CYP2J2 Molecular Recognition: A New Axis for Therapeutic Design", Pharmacology and Therapeutics, 2020, Jun 11;107601. doi: 10.1016/j.pharmthera.2020.107601.
Watson, J, Kim, J. and Das, A* "Emerging class of omega-3 fatty acid endocannabinoids & their derivatives", Prostaglandins and Other Lipid Mediators (POLM), 2019, 11, 143
Roy, J., Watson, J., Hong, I., Fan, T., and Das, A*, "Anti-tumorigenic properties of omega-3 endocannabinoid epoxides" J. Med. Chem, 2018, 61, 5569
McDougle, D.R., Watson, J., Abdeen,A., Adili, R., Caputo, M., Krapf, J., Johnson, R., Kilian, K., Holinstat, M., Das, A*, "Anti-inflammatory Omega-3 Endocannabinoid Epoxides", Proceedings of National Academy of Sciences (PNAS) (Direct Submission, Track II), 2017 https://doi.org/10.1073/pnas.1610325114
MINOR CANNABINOID METABOLISM (SELECTED PUBLICATIONS)
Pritam Roy, ‡, Jonathan Maturano†,a,b, Hale Hasdemirc, Angel Lopez‡, Fengyun Xud, , Judith Hellmand, Emad Tajkhorshidb,c, David Sarlah*,a,b and Aditi Das*, ‡Elucidating the Mechanism of Metabolism of Cannabichromene (CBC) by Human Cytochrome P450s. 2024, ACS- Journal of Natural Products, https://pubs.acs.org/doi/10.1021/acs.jnatprod.3c00336
Roy, P*., Dennis, D*., Eschbach, M., Anand, D., Hellman, J. Sarlah, D. * and Das, A*., "Metabolism of Cannabigerol by Human Liver Cytochrome P450s leading to bioactive CBG metabolites." 2022, ACS-Biochemistry
Dennis, D., Anand, D., .... ., Das, A*, Sarlah, D*, "Synthesis of Cannabimovone and Cannabifuran Class of Minor cannabinoids and Their Anti-inflammatory Activity," 2022, Journal of Organic Chemistry, https://pubs.acs.org/doi/10.1021/acs.joc.2c00336
Dutta,S., Selvam,B., Das, A. and Shukla, D*., Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors 2022, Journal of Biological Chemistry, DOI:https://doi.org/10.1016/j.jbc.2022.101764
All Publications
In preparation
78. Arnold, W., Jain, S., and Das, A*, "The Hunt for the Putative Epoxyeicosatrienoic Acid Receptor", In preparation
77. Das, A*,"Recent development in Nanodiscs for Biophysical Studies (2018-2024). In preparation
76. Tang, T., Chapman, P., Das, A.*, "Comparative study of drug metabolism by CYP2D6 and CYP2U1 in Nanodiscs". In preparation
75. Kim, J., Mancini, F., Dennisouk, A., Orlandi, C., Das, A.*, "Glycine derivative of poly unsaturated fatty acids are antagonist of orphan GPCRS" In preparation
74. Kundu, D., Maturano, J., Mancini, F., Xud, F. , Hellman,J., Orlandi, C. Sarlah, D.* and Das, A.*, "Cannabinol metabolism by human cytochrome P450s leads to diverse metabolites with novel molecular pharmacology." In preparation
SUBMITTED
73. Li, J., Smith, J. K.Y. Huang, Wang, H., Das, A., Kong, H., and Chen, Q., "Correlative Electron Microscopy Imaging of Proteins and Cells" 2024, Microscopy & Microanalysis , submitted
72. Eschbach, M.D., Abdallah, G., Lopez, A.J., Roy, P.R., Anand, D. and Das, A*. "Omega-3 Endocannabinoid Epoxide Enantiomers formed by Human Cytochrome P450s are bioactive." 2024, Submitted
BOOK CHAPTERS
71. Tang Yi ChienG and Das, A.* (2023) Role of Omega-3 and Omega-6 Endocannabinoids in Cardiopulmonary Pharmacology, Advances in Pharmacology Volume 97, Book Chapter. 375-422. doi: 10.1016/bs.apha.2023.02.003. (Special invited book chapter)
70. Carnevale, L., and Das, A*, (2019) "Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers", Book Chapter, Bioactive Lipids in Cancer, Inflammation and Related Diseases. Advances in Experimental Medicine and Biology (AEMB). 1161:219-232. doi: 10.1007/978-3-030-21735-8_17. (Special invited book chapter)
69. Maroutsos,D., Huff, H., Das, A*., (2019) "Bacterial Expression of Membrane-Associated Cytochrome P450s and Their Activity Assay in Nanodiscs, Book Chapter, Microbial Metabolic Engineering. Methods in Molecular Bioligy 1927: 47-72. doi: 10.1007/978-1-4939-9142-6_5. (Special invited book chapter).
2024 PUBLISHED
68. Cannabinoids
Roy,P., Maturano, J., Hasdemir,H., Lopez, A., Xud, F. , Hellman,J., Tajkhorshid,E., Sarlah, D.* and Das,A.*, Elucidating the Mechanism of Metabolism of Cannabichromene (CBC) by Human Cytochrome P450s. 2024, ACS- Journal of Natural Products, https://pubs.acs.org/doi/10.1021/acs.jnatprod.3c00336
67. Cytochrome P450 Biophysics
Smith, J., Carnevale, L., Das, A*, Chen, Q.*,"Electron Videography of a Lipid–Protein Tango", 2024, Science Advances doi: 10.1126/sciadv.adk0217.2024
66. Lipid Mediators
Huff, H.C., §, Kim,J.S. and Das, A*.,"Real time changes in the expression of cyclooxygenase, lipoxygenase, and cytochrome P450s during inflammation" 2024, Prostaglandins Other Lipid Mediators 2024, 106839.
Line graphs demonstrating relative expression over time of Non-LPS control (black) vs LPS (red) stimulation of inflammatory genes in macrophages.
2023
65. Lipid Mediators
Kim,J., Soto-Diaz, K., Bingham, T., Steelman, A.J * and Das, A.* Role of Omega-3 Endocannabinoids in the Modulation of T-cell Activity in a Multiple Sclerosis EAE Model. 2023, Journal of Biological Chemistry., 102886.
64. Cannabinoids
Sangiamo, D.T, Weingarten, M.J, Choi, C.Y., Das, A. and Liang, Nu-Chu*, "Consumption of dronabinol altered daily feeding patterns and affected alcohol-related changes in frontal endocannabinoid levels in male rats", 2023, Behavioral Brain Research, ASAP
63. Louie, A*., Kim, J*., Soto-Diaz, K., Dibaeinia, P., Koito, H., Sinha, S., Nowak, R. Das, A*., Steelman, A*.,“Influenza A virus infection disrupts oligodendrocyte homeostasis and alters the myelin lipidome in the adult mouse". 2023, Journal of Neuroinflammation, Accepted (impact factor:9.5)
62. Cannabinoids
Torrens, A., Ruiz, Christina., Roy, P., Grimes, D., Ahmed, F., Huestis, M., Mahler, S., Das, A., Piomelli, D.* "Nasal Accumulation and Metabolism of 9-Tetrahydrocannabinol Following Aerosol Administration in Adolescent Rats" 2023, Pharmacological Research, doi: 10.1016/j.phrs.2022.106600.
2022
61. Cannabinoids and CYP Biophysics
Roy, P*., Dennis, D*., Eschbach, M., Anand, D., Hellman, J. Sarlah, D. * and Das, A*., "Metabolism of Cannabigerol by Human Liver Cytochrome P450s leading to bioactive CBG metabolites." 2022, Biochemistry, 2398
60. Biophysics
Ulusan,S., Sheraj, I., Stehling,S., Ivanov, I., Das, A., Kuhn, H., Banerjee, S*. Structural and functional evaluation mammalian and plant lipoxygenases upon association with nanodics as membrane mimetics. 2022, Biophysical Chemistry, DOI: 10.1016/j.bpc.2022.106855
59. Cannabinoids
Dennis DG, Anand SD, Lopez AJ, Petrovčič J, Das A*, Sarlah D*, "Synthesis of Cannabimovone and Cannabifuran Class of Minor cannabinoids and Their Anti-inflammatory Activity," 2022, Journal of Organic Chemistry, 6075.
58. Xie , Feng., Cai, McCarthy, Wang, Zhao, Zang, Yuan, Hu, Li, Liu, Das, A., England, S. and Hu, H.*, "Activation of nociceptor by estrogen metabolites: a peripheral mechanism underlying sex differences in pain perception?" 2022, Journal of Clinical Investigation Insight, https://insight.jci.org/articles/view/149107
57. Dutta,S., Selvam,B., Das, A. and Shukla, D*., Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors 2022, Journal of Biological Chemistry, DOI:https://doi.org/10.1016/j.jbc.2022.101764
56. Torrens, A., Roy, P., Lin, L., Vu, C., Grimes, D., Inshishian, V., Montesinos, Ahmed, Mahler, S., Huestis, M., Das, Aditi, Piomelli, D*., "Comparative Pharmacokinetics of Δ9-Tetrahydrocannabinol in Adolescent and Adult Rats of Both Sexes." 2022, Cannabis and Cannabinoid Research https://doi.org/10.1089/can.2021.0205
55. Kim, J*., Arango, A*., Shah, S., Arnold, W., Tajkhorshid, E., Das, A*., "Anthracycline derivatives inhibit cardiac CYP2J2" J Inorg Biochem. 2022 doi: 10.1016/j.jinorgbio.2022.111722.
2021
54. Huff, H., Vasan, A., Roy, P., Kaul, A., Tajkhorshid, E*., and Das, A*., "Differential Interactions of Selected Phytocannabinoids with Human CYP2D6 Polymorphisms", ACS-Biochemistry, 2021, 60, 2749.
53B. Arnold, W., Carnevale, L., Xie, Z., Baylon, J., Tajkhorshid, E., Hu, H., Das, A.*, "Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel " Nature Communications, 2021, https://www.nature.com/articles/s41467-021-20946-6
Science Daily: https://www.sciencedaily.com/releases/2021/02/210210091142.htm
Illinois: https://news.illinois.edu/view/6367/2092420617
Eureka Alert: https://www.eurekalert.org/pub_releases/2021-02/uoia-let020821.php
2020
53A. Arnold, W., Carnevale, L., Xie, Z., Baylon, J., Tajkhorshid, E., Hu, H., Das, A.*, "Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel " BioRxiv, 2020. https://www.biorxiv.org/content/10.1101/2020.05.05.079624v1
52. Das, A.*, Arnold, W.*, Weigle, A.*, Kim, J., Carnevale, L., and Huff, H., "CYP2J2 Molecular Recognition: A New Axis for Therapeutic Design", Pharmacology and Therapeutics, 2020, 151-160.
51. Torrens,A., Vozella, V., Huff, H., McNeil, B., Ahmed, Ghidini, Mahler, Huestis, Das, A. and Daniele Piomelli. Comparative Pharmacokinetics of 9-Tetrahydrocannabinol in Adolescent and Adult Male Mice. Journal of Pharmacology and Experimental Therapeutics, 2020, doi: 10.1124/jpet.120.265892
50. Chen,A., Yeung, J., Szatkowski,A., Jackson, M., Freedman, C., Das, A., Holman, T., and Holinstat, M., "Omega-6 DPA and its 12-lipoxygenase oxidized lipids regulate platelet reactivity in a non-genomic PPARα-dependent manner" Blood Advances, 2020, 4522-4537.
49. Yadav, C. Reinhardt, H. Huff, M, Malkoswki, Das, A, Tajkhorshid, E., and J. Chan. "CoxFluor: An activity-based fluorescence probe for cyclooxygenase-2 (COX-2)", Angew Chem Int Ed Engl. 2020, doi: 10.1002/anie.201914845
( * denotes corresponding author or first author)
2019
48. Smith,J., Carnevale, L., Das, A*., and Qian Chen* "Real-time Electron Microscopy of Protein Nanodiscs in Graphene Liquid Cells", Microscopy and Microanalysis, 2019, 25 (S2), pp 1498-1499
47. Arnold, W., Meling, D., Zelasko, S. and Das, A*. "CYP2C8 polymorphisms causes disruption of the electron transfer between CYP and CPR", International Journal of Molecular Science, 2019, Accepted.
46. Li, Nader; Zhang, X. Ray,B., Kim, CY, Das, A., Witola, W.,"Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum" PLOS Pathogens, 2019, Accepted
45. Caputo,M., Radlowski, E., Lawson, M., Antonson, A., Watson, J., Matt, S., Leyshon, B., Das, A., and Johnson, R., "Herring Roe Oil Supplementation Alters Microglial Cell Gene Expression and Reduces Peripheral Inflammation After Immune Activation in a Neonatal Piglet Model", Brain, Behavior and Immunity, 2019, 30160.
44. Watson, J, Kim, J. and Das, A* "Emerging class of omega-3 fatty acid endocannabinoids & their derivatives", Prostaglandins and Other Lipid Mediators (POLM), 2019, 11, 143
43. Huff, H.,Maroutsos, D., and Das, A*,"Macromolecular Crowding and Lipid Composition Controls CYP2J2 activity. Protein Science, 2019, 28,928-940.
42. Roy, J., Fan, T., Payam, Sinha S., and Das, A*, "Global Analysis of Osteosarcoma Lipidomes Reveal Altered Lipid Profiles in Metastatic vs. Non-Metastatic Cells" Journal of Lipid Research, 2019, 60, 375-387
41. Nelson, N., Law, Weingarten,W., Carnevale, L., Das, A. Liang, Nu-Chu, "Subcutaneous or oral delta9-tetrahydrocannabinol administration in combination with moderate alcohol consumption differently alter ingestive behaviors in adolescent rats", Psychopharmacology, 2019, 236,671-684.
2018
40. Carnevale, L., Arango, A., Arnold, W., Tajkhorshid, E*., and Das, A*,"Endocannabinoid Virodhamine Inhibits Cardiovascular CYP2J2 epoxygenase", Biochemistry, 2018, 57,6489-6499.
39. Roy, J., Watson, J., Hong, I., Fan, T., and Das, A*, "Anti-tumorigenic properties of omega-3 endocannabinoid epoxides" J. Med. Chem, 2018, 61, 5569
In News: https://news.illinois.edu/view/6367/670666
Current Altmetric Score: 217
Highlighted in https://acs.altmetric.com/details/43321817/news
38. Arnold, W., and Das, A*,"An Emerging Pathway of Doxorubicin Cardiotoxicity Mediated through CYP2J2, Biochemistry, 2018, 57, 2294
Gordon Hammes Scholar Award runner up.
In News: https://beckman.illinois.edu/news/2018/04/doxorubicin-and-cardiotoxicity
37. Roy, J. Pondenis, H., Fan T.*, Das, A*, "Comparative Proteomic Analysis of Metastatic and Non-metastatic Osteosarcoma of Human and Canine Origin" PLOS One, 2018 e0183930. doi: 10.1371/journal.pone.0183930.
36. Arnold, W., Weigle, A. and Das, A*, "Crosstalk of Endocannabinoids and Cannabinoids metabolism is mediated by CYP2J2 epoxygenase" Journal of Inorganic Chemistry, 2018, 184, 88
2017
35. Arnold, W., Baylon, J., Tajkhorshid, E.* and Das, A*. "Arachidonic Acid Metabolism by Human Cardiovascular CYP2J2 Is Modulated by Doxorubicin." Biochemistry, 2017, 56 (51), pp 6700–6712
F1000 Prime Recommended!!
34. McDougle, D.R., Watson, J., Abdeen,A., Adili, R., Caputo, M., Krapf, J., Johnson, R., Kilian, K., Holinstat, M., Das, A*, "Anti-inflammatory Omega-3 Endocannabinoid Epoxides", PNAS (Direct Submission), 2017 https://doi.org/10.1073/pnas.1610325114
Highlighted in Forbes
Highlighted in Bioscience Technology
Highlighted in Nutrition Insight
Highlighted in New Medical Life Sciences
Highlighted in Eurekalert
33. Rouck, J.*, Krapf, J.* Roy, J. Huff, H. and Das, A.*, "Recent Advances in Nanodisc Technology for studying Membrane Proteins (2012-2017)". FEBS Letters 2017, Accepted
32. Rouck*, J.E., Bradley*, WB.,Kambalyal, A.,Parayil, A*. and Das, A*., "Expression and Purification of cytochrome P450 taxadiene 5alpha-hydroxylase in E.Coli", Protein Expression and Purification, Protein Expr Purif. 2017 Jan 18;132:60-67.
2016
31. Arnold, W., Baylon, J, Tajkorshid, E.* and Das, A.*,"Asymmetric Binding and Metabolism of Polyunsaturated Fatty Acids (PUFAs) by CYP2J2 Epoxygenase" Biochemistry. 2016, 55(50):6969-6980.
30. Roy, J. Adili, Raymond, Kulmacz, R., Holistat, M., and Das, A*,"Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function", Journal of Pharmacology and Experimental Therapeutics, 2016 Oct;359(1):134-41.
29. Bradley*, WB., Rouck*, J.E., Kambalyal, A., Das, A*. and Parayil, A*., "Orthogonal assays uncover enzyme promiscuity and chemical isomerization and remove ambiguity surrounding key P450 mediated oxygenation in Taxol biosynthesis". ACS-Chemical Biology, 2016, 11 (5), 1445–1451.
28. Plucinski, L., Gartia, M., Arnold, W., Ameen, A., Chang, T., Hsiao, A., Liu, G.*, Das, A.*, "Substrate Binding to CYP2J2- Nanodiscs Detected by Nanoplasmonic Lygurcus Cup Arrays" Biosens Bioelectron., 2016, 337-46.
d0i: 1016/j.bios.2015.07.041
27. Lim, SJ, McDougle, D., Das, A* and Smith, A.*, "Lipoprotein Nanoplatelets: Fluorescent, Zwitterionic Probes for Molecular and Cellular Imaging." J. Am. Chem. Soc., 2016, 138 (1), pp 64–67
2015
26. Roy, J. Pondenis, H., Fan T.*, Das, A*, "Direct Capture of Functional Proteins from Mammalian Plasma Membranes into Nanodiscs" Biochemistry, 2015, 6299–6302.
25. McDougle, D*., Baylon, J.* Meling D., Kambalyal, A., Tajkorshid, E.*, and Das, A* "Incorporation of Charged Residues in the CYP2J2 F-G Loop Disrupts CYP2J2-Lipid Bilayer Interactions" Biochimica et Biophysica Acta -Biomembranes, 2015, 2060-2470.
24. Zelasko, S, Meling, D. and Das A*. "A critical residue that controls the isomerization of prostaglandin in thromboxane synthase", Biophysical Chemistry, 2015, 34-40.
23. Wilcox, K., Das, A., Velasco, P., Sligar S.G. and Klein, W. "Nanoscale synaptic membrane mimetic allows unbiased high throughput screen that targets binding sites for Alzheimer’s-associated Aβ oligomers" 2015, PLOS ONE In Press
22. Zelasko, S., Arnold, W., Das, A* " Endocannabinoid Metabolism by Cytochrome P450 Monooxygenases.", Prostaglandins and Other Lipid Mediators. 2015.
(News: Most downloaded article is at POLM)
2014
21. McDougle, D., Kambalayal, A., Meling, D. and Das, A*. "Endocannabinoids - Anandamide and 2- Arachidonoylglycerol are Substrates for Human CYP2J2 Epoxygenase" Journal of Pharmacology and Experimental Therapeutics, 2014, 616-27.
20. Meling, D., McDougle, D. and Das, A.*,"CYP2J2 epoxygenase membrane anchor plays an important role in facilitating electron transfer from CPR." Journal of Inorganic Biochemistry 2014, 47-53.
19. Orlando, B., McDougle, D., Lucido, M., Eng, E., Stokes, D., Das, A*., and Malkowski, M*. "Cyclooxygenase-2 Catalysis and Inhibition in Lipid Bilayer Nanodiscs" Archives of Biochemistry and Biophysics 2014, 546, 33-40.
18. Srivarma, S., Mularcyzk, C. Meling, D. and Das, A*. "Substrate binding thermodynamics and kinetics to thromboxane synthase in model lipid bilayers", ChemBioChem. 2014, 15, 892
2013
17. Zelasko S., Palaria, A., and Das, A* "Modifications to produce high-level expression of mammalian cytochrome P450s in recombinant expression systems" Protein Expression and Purification, 2013,92,77-87
16. McDougle, D*., Palaria, A.*Magnetta E., Meling, D. and Das, A*. "Functional Studies of N-terminally modified CYP2J2 epoxygenase in Model Lipid Bilayers", Protein Science, 2013, 22,964 (Amrita Palaria and Daniel McDougle are equal authors)
***************(Before start of faculty position)********************
15. Marty, M., Das, A., Sligar, S.G. “Ultra-thin layer MALDI mass spectrometry of membrane proteins in nanodiscs”, Analytical Bioanalytical Chemistry, 2012, 402, 721.
14. Turk, S., Das, A., Sligar, S. G. and Dravid, V. “Nanomechanical Detection of Cholera Toxin Using Microcantilevers Functionalized with Ganglioside-Nanodiscs” Nanotechnology, 2010, 21, 435502.
13. Das, A., Wei, Y., Pelczer, I. and Hecht, M.H. “Binding of Small Molecules to Cavity Forming Mutants of a De Novo Designed Protein”, Protein Science, 2011, 20, 702–711.
(In News) Editor Highlight in Protein Science
(In News): Nanomechanical sensor can detect cholera. Nanowerk Spotlight
12. Das, A. and Sligar, S.G. “Modulation of the Cytochrome P450 Reductase Redox Potential by the Phospholipid Bilayer” Biochemistry, 2009, 48(51), 12104-12.
11. Das. A., Zhao, J. Van Duyne, R. and Sligar, S.G. “Screening of Type I and II Drug Binding to Human Cytochrome P450-3A4 in Nanodiscs by Localized Surface Plasmon Resonance Spectroscopy”, Anal. Chem., 2009, 81 (10), 3754–3759.
10. Li, H., Das, A., Sibhatu, H., Jamal, J., Sligar, S. and Poulos, T.L. “Exploring the Electron Transfer Properties of Neuronal Nitric Oxide Synthase by Reversal of the FMN Redox Potential” J. Biol. Chem. 2008, 283 (50), 34762-34772.
9. Zhao,J., Das, A. Sligar, S.G. and Van Duyne, R. “Resonance Localized Surface Plasmon Spectroscopy: Sensing Substrate & Inhibitor Binding to Cytochrome P450” J. Phys. Chem. C.2008, 112 (34), 13084-13088.
8. Gruia,F., Ionascu,D. , Kubo, M. Ye, X., Dawson, J., Osborne, R.L., Sligar, S. G., Denisov, I., Das, A. Poulos, T. L., Terner, J. and Champion, P.M. “Low Frequency Dynamics of Caldariomyces fumago Chloroperoxidase Probed by Femtosecond Coherence Spectroscopy” Biochemistry 2008, 47(18), 5156-5167.
7. Das. A., Grinkova, Y. and Sligar, S.G. “Redox Potential Control by Drug Binding to Cytochrome P450 3A4.” J. Am. Chem. Soc. 2007, 129 (45), 13778-13779
6. Das, A. and Hecht, M. H. “Peroxidase Activity of De Novo Heme Proteins Immobilized on Electrodes.” J. Inorg. Biochem. 2007, 101 (11-12), 1820-1826
5. Kimmich, N., Das. A., Sevrioukova, I, Meharenna, Y., Sligar, S.G. and Poulos, T. L. “Electron Transfer between P450cin and its FMN-Containing Redox Partner” J. Biol. Chem., 2007, 282 (37), 27006-27011
4. Zhao*, J., Das, A.*, Zhang, X, Schatz, G., Sligar, S., Van Duyne, R. “Resonance Surface Plasmon Spectroscopy: Low Molecular Weight Substrate Binding to Cytochrome P450” J. Am. Chem. Soc. 2006, 128 (34), 11004-11005. (* Co-first authors)
(In News): (1) Enhanced LSPR detects binding of small molecules. Anal. Chem., 2006, 78(21), 7356. (2) Kirrill’s Café paper of the month. August 2006
3. Das, A., Trammell, S. A. and Hecht, M. H. “Electrochemical and Binding Studies of an immobilized De Novo Heme Protein” Biophy. Chem. 2006, 123 (2-3), 102-112.
2. Hu, Y., Das, A., Hecht, M. H. and Scoles, G. “Nanografting De Novo Proteins onto gold surface” Langmuir 2005, 21(20), 9103-9109.
1. Hecht, M.H., Das, A., Go, A., Bradley, L. and Wei, Y. (2004) “De Novo Proteins from Designed Combinatorial Libraries.” Protein Science 2004, 13(7), 1711–1723.
THESIS
Das, A. “Electrochemical and Functional Studies of De Novo Alpha Helical Protein from a Designed Combinatorial Library.” Ph.D Thesis Princeton University November 2005
Das, A. Model Chemistry of Aerobic Acetylene Hydratase Enzymes. M.Sc. Thesis: I.I.T (Kanpur) 1998
BOOK CHAPTER
Maroutsos, D., Huff, H., and Das, A*, "N-terminal modification to increase expression of Eukaryotic P450s in E.Coli - CYP5alpha Hydroxylase and CYP2J2 epoxygenase" Methods in Molecular Biology, Book Chapter.
PATENTS
• Das, A. and Watson, J., “EPA endocannabinoid derivatives as Anti-inflammatory and Anti-pain drugs”, US Patent Application 2017-168-01
• Das, A. and Ray, J., “DHA endocannabinoid derivatives as Anti-inflammatory and Anti-pain drugs”, US Patent Application 2017-167-01.
• Smith, A., Lim, S.J., Das, A., “Lipoprotein Nanoplatelets: Fluorescent, Zwitterionic Probes for Molecular and Cellular Imaging” US Patent Application 15/244,026
• Das, A. and Ray, J., “Aspirin derivatives of Omega-3 fatty acids”, Invention Disclosure.
PAPERS IN GESTATION
Endocannabinoid metabolism by Cytochrome P450s
Tang, Yi-Chien and Das, A*, " Substrate selectivity in CYP2U1 in Nanodiscs"
Kim and Das, A*, "Mechanistic understanding of the generation and metabolism of bioactive DHA based endocannabinoids in the central nervous system"
EET receptors: Are we there yet? Manuscript in preparation, Review
Role of Endocannabinoids and oxy-endocannabinoids in Cancer, Review
Cannabinoid metabolism by cytochrome P450s
Kundu and Das, A*, "Metabolism of cannabinol by P450s, the active metabolites in sleep induction"
Computational modeling and prediction of agonism and antagonism of cannabinoid receptor 1 and 2 by synthetic and naturally occurring cannabinoids, with Shukla Group.